| scholarly article | Q13442814 |
| P2093 | author name string | Xi Chen | |
| Qiang Li | |||
| Haitao Lu | |||
| Qiao Su | |||
| Yumei Que | |||
| Yana Lv | |||
| P2860 | cites work | Accurate microRNA target prediction correlates with protein repression levels | Q21284375 |
| Fast and effective prediction of microRNA/target duplexes | Q24537313 | ||
| miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling | Q24627398 | ||
| Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development | Q24628811 | ||
| MicroRNA targets in Drosophila | Q24806738 | ||
| Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid | Q27021933 | ||
| Combinatorial microRNA target predictions | Q27860510 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Switching from repression to activation: microRNAs can up-regulate translation | Q28131790 | ||
| Missing value estimation methods for DNA microarrays | Q28200763 | ||
| Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs | Q28248709 | ||
| Network pharmacology: the next paradigm in drug discovery | Q28297997 | ||
| The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest | Q28484878 | ||
| miRDB: a microRNA target prediction and functional annotation database with a wiki interface | Q28754510 | ||
| The role of site accessibility in microRNA target recognition | Q29547436 | ||
| A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes | Q29616620 | ||
| WEGO: a web tool for plotting GO annotations | Q29616658 | ||
| An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin | Q30393827 | ||
| limmaGUI: a graphical user interface for linear modeling of microarray data | Q33205531 | ||
| Activation of p53 promotes renal injury in acute aristolochic acid nephropathy | Q33562197 | ||
| p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest | Q33719450 | ||
| p53 is positively regulated by miR-542-3p | Q33758261 | ||
| Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo. | Q34001986 | ||
| Ten novel RB1 gene mutations in patients with retinoblastoma. | Q34007805 | ||
| Unambiguous detection of multiple TP53 gene mutations in AAN-associated urothelial cancer in Belgium using laser capture microdissection | Q34128720 | ||
| Induction of growth arrest by miR-542-3p that targets survivin. | Q34132476 | ||
| Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma | Q34152578 | ||
| Variation in presentation and presence of DNA adducts and p53 mutations in patients with endemic nephropathy--an environmental form of the aristolochic acid nephropathy | Q86212277 | ||
| Traditional Chinese medicine network pharmacology: theory, methodology and application | Q86982948 | ||
| Expression of histone deacetylase-1 and p300 in aristolochic acid nephropathy models | Q87812146 | ||
| Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava | Q34287632 | ||
| microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer | Q34299181 | ||
| Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs | Q34331393 | ||
| MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-β Mediates the migration and actin dynamics of breast cancer cells | Q34332277 | ||
| MicroRNA-24 antagonism prevents renal ischemia reperfusion injury | Q34568822 | ||
| Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells. | Q34620119 | ||
| microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma. | Q36230642 | ||
| MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene | Q36621766 | ||
| Chemical and molecular basis of the carcinogenicity of Aristolochia plants | Q37371808 | ||
| Screening plasma miRNAs as biomarkers for renal ischemia-reperfusion injury in rats | Q37607442 | ||
| A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury | Q37629173 | ||
| miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. | Q37681865 | ||
| The long and short of microRNA. | Q38102186 | ||
| Network pharmacology in traditional chinese medicine. | Q38269825 | ||
| Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice | Q38507093 | ||
| miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells | Q38991056 | ||
| miR-584 expressed in human gingival epithelial cells is induced by Porphyromonas gingivalis stimulation and regulates interleukin-8 production via lactoferrin receptor | Q39063258 | ||
| miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma | Q39146500 | ||
| JNK-dependent AP-1 activation is required for aristolochic acid-induced TGF-β1 synthesis in human renal proximal epithelial cells. | Q39375030 | ||
| The proto-oncogene Pim-1 is a target of miR-33a | Q39509450 | ||
| MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma | Q39521098 | ||
| miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. | Q39677748 | ||
| Mechanism of chronic aristolochic acid nephropathy: role of Smad3. | Q39749821 | ||
| A network pharmacology approach to determine active compounds and action mechanisms of ge-gen-qin-lian decoction for treatment of type 2 diabetes | Q41907526 | ||
| Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites | Q42419115 | ||
| Induction of urothelial proliferation in rats by aristolochic acid through cell cycle progression via activation of cyclin D1/cdk4 and cyclin E/cdk2. | Q42481303 | ||
| Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue | Q44484798 | ||
| Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer | Q45011091 | ||
| Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer | Q45740901 | ||
| miR-192 induces G2/M growth arrest in aristolochic acid nephropathy | Q45841408 | ||
| TGF-beta 1/Smads signaling stimulates renal interstitial fibrosis in experimental AAN. | Q45916809 | ||
| TargetMiner: microRNA target prediction with systematic identification of tissue-specific negative examples. | Q45963529 | ||
| A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study | Q47673982 | ||
| Molecular markers in upper urothelial carcinoma associated to Balkan endemic nephropathy. Aristolochic acid as the major risk factor of the worldwide disease. | Q53353065 | ||
| Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. | Q53431796 | ||
| microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells. | Q54193852 | ||
| [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues]. | Q54323844 | ||
| Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy | Q56267128 | ||
| Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy | Q61775751 | ||
| [MicroRNAs and kidneys] | Q85271214 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| limma | Q112236343 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioinformatics | Q128570 |
| biomarker | Q864574 | ||
| P304 | page(s) | 52270-52280 | |
| P577 | publication date | 2016-07-13 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Bioinformatics facilitating the use of microarrays to delineate potential miRNA biomarkers in aristolochic acid nephropathy | |
| P478 | volume | 7 |
| Q50068087 | Investigation into the underlying molecular mechanisms of hypertensive nephrosclerosis using bioinformatics analyses |
| Q65001396 | Systematic Overview of Aristolochic Acids: Nephrotoxicity, Carcinogenicity, and Underlying Mechanisms. |
| Q64072379 | TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility |
Search more.